159 related articles for article (PubMed ID: 36740149)
21. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
Liu Y; Zhu J; Ding L
Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
[TBL] [Abstract][Full Text] [Related]
22. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
[TBL] [Abstract][Full Text] [Related]
23. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
24. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
25. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.
Deng J; Zhang Q; Lv L; Ma P; Zhang Y; Zhao N; Zhang Y
Sci Rep; 2022 Apr; 12(1):7006. PubMed ID: 35488119
[TBL] [Abstract][Full Text] [Related]
26. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma.
Tang R; Zhang Y; Liang C; Xu J; Meng Q; Hua J; Liu J; Zhang B; Yu X; Shi S
PeerJ; 2020; 8():e9602. PubMed ID: 33062408
[TBL] [Abstract][Full Text] [Related]
27. M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.
Xu F; Zhang Z; Yuan M; Zhao Y; Zhou Y; Pei H; Bai L
Cancer Invest; 2021 Jan; 39(1):39-54. PubMed ID: 33176521
[TBL] [Abstract][Full Text] [Related]
28. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma.
Zhang Q; Lv L; Ma P; Zhang Y; Deng J; Zhang Y
Front Immunol; 2021; 12():743938. PubMed ID: 34956177
[TBL] [Abstract][Full Text] [Related]
29. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
30. Construction of an efferocytosis-related long non-coding ribonucleic acid scoring system to predict clinical outcome and immunotherapy response in pancreatic adenocarcinoma.
Zhou C; Gan X; Sun S; Wang L; Zhang Y; Zhang J
Biochem Biophys Rep; 2023 Sep; 35():101540. PubMed ID: 37692763
[TBL] [Abstract][Full Text] [Related]
31. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
32. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Yu X; Zhang Q; Gao F; Zhang M; Zheng Q; He Y; Guo W
Sci Rep; 2021 Sep; 11(1):17529. PubMed ID: 34471186
[TBL] [Abstract][Full Text] [Related]
33. An immune-related gene prognostic risk index for pancreatic adenocarcinoma.
Su Y; Qi R; Li L; Wang X; Li S; Zhao X; Hou R; Ma W; Liu D; Zheng J; Shi M
Front Immunol; 2022; 13():945878. PubMed ID: 35958614
[TBL] [Abstract][Full Text] [Related]
34. CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling.
Nie Y; Liu C; Liu Q; Zhu X
BMC Cancer; 2023 Feb; 23(1):150. PubMed ID: 36782176
[TBL] [Abstract][Full Text] [Related]
35. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
Zheng X; Liu X; Zheng H; Wang H; Hong D
Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract][Full Text] [Related]
37. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
39. Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma.
Huang W; Li J; Zhou S; Li Y; Yuan X
Front Endocrinol (Lausanne); 2022; 13():883548. PubMed ID: 35800432
[TBL] [Abstract][Full Text] [Related]
40. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
